Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ (2,247)	$ (9,537)	$ (8,788)	$ (1,247)	$ (13,758)	$ (12,550)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation, depletion, accretion, and amortization					6,392	8,181
Impairment of oil and natural gas properties	1,424		6,495		6,843	6,495
Deferred income taxes					(14)	(452)
Total commodity derivatives (gains) losses, net					(537)	(704)
Commodity derivative settlements received (paid)					2,381	(642)
(Gains) losses on marketable equity securities					57	(54)
Impairment and loss on real estate held for sale					11	0
Amortization of debt issuance costs					37	37
Stock-based compensation					950	1,951
Right of use asset amortization					123	135
Changes in operating assets and liabilities:
Oil and natural gas sales receivable					920	(292)
Other assets					(174)	395
Accounts payable and accrued liabilities					80	120
Accrued compensation and benefits					(91)	(294)
Revenue and royalties payable					(88)	927
Payments on operating lease liability					(136)	(145)
Payments of asset retirement obligations					(105)	(131)
Net cash provided by operating activities					2,891	2,977
Cash flows from investing activities:
Acquisition of helium properties					(2,368)	0
Helium capital expenditures					(1,599)	0
Capital expenditures					(1,158)	(2,878)
Property and equipment expenditures					(189)	(487)
Proceeds from sale of oil and natural gas properties, net					5,866	0
Proceeds from sale of real estate assets					139	0
Net cash provided by (used in) investing activities					691	(3,365)
Cash flows from financing activities:
Borrowings on credit facility					2,000	500
Payments on credit facility					(7,000)	(500)
Payments on insurance premium finance note					(62)	(465)
Shares withheld to settle tax withholding obligations for restricted stock awards					(132)	(151)
Dividends paid					0	(1,192)
Repurchases of common stock					(584)	(241)
Net cash provided by (used in) financing activities					(5,778)	(2,049)
Net (decrease) increase in cash and equivalents					(2,196)	(2,437)
Cash and equivalents, beginning of period		$ 3,351		$ 4,411	3,351	4,411	$ 4,411
Cash and equivalents, end of period	$ 1,155		$ 1,974		$ 1,155	$ 1,974	$ 3,351